These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6850535)

  • 61. A prospective comparative clinical study of peripheral blood counts and indices in patients with primary brain tumors.
    Subeikshanan V; Dutt A; Basu D; Tejus MN; Maurya VP; Madhugiri VS
    J Postgrad Med; 2016; 62(2):86-90. PubMed ID: 27089106
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES.
    Lim KG; Wan HC; Bozza PT; Resnick MB; Wong DT; Cruikshank WW; Kornfeld H; Center DM; Weller PF
    J Immunol; 1996 Apr; 156(7):2566-70. PubMed ID: 8786320
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Elevated circulating levels of eosinophil cationic protein in uremia as signs of abnormal eosinophil homeostasis.
    Hällgren R; Grefberg N; Venge P
    Nephron; 1984; 36(1):10-4. PubMed ID: 6690999
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo.
    Cottin V; Deviller P; Tardy F; Cordier JF
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):116-23. PubMed ID: 9449510
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Eosinophil soluble protein levels, eosinophil peroxidase and eosinophil cationic protein in asthmatic patients.
    Parra A; Sanz ML; Vila L; Prieto I; Diéguez I; Oehling AK
    J Investig Allergol Clin Immunol; 1999; 9(1):27-34. PubMed ID: 10212854
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of the blood eosinophil count with hematological malignancies and mortality.
    Andersen CL; Siersma VD; Hasselbalch HC; Vestergaard H; Mesa R; Felding P; Olivarius ND; Bjerrum OW
    Am J Hematol; 2015 Mar; 90(3):225-9. PubMed ID: 25488524
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Social support and immune status during and after chemotherapy for breast cancer.
    Lekander M; Fürst CJ; Rotstein S; Blomgren H; Fredrikson M
    Acta Oncol; 1996; 35(1):31-7. PubMed ID: 8619937
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Study of E rosettes, serum IgE and eosinophilia in asthmatic children.
    Hsieh KH
    Ann Allergy; 1976 Dec; 37(6):383-90. PubMed ID: 793456
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mechanism of eosinophilia. II. Role of the lymphocyte.
    Basten A; Beeson PB
    J Exp Med; 1970 Jun; 131(6):1288-305. PubMed ID: 5419272
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Depletion of eosinophils by anti-IL-5 monoclonal antibody treatment of mice infected with Trichinella spiralis does not alter parasite burden or immunologic resistance to reinfection.
    Herndon FJ; Kayes SG
    J Immunol; 1992 Dec; 149(11):3642-7. PubMed ID: 1431133
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term (5-11 years) follow-up of general immune competence in breast cancer. I. Pre-treatment levels with reference to micrometastasis.
    Shukla HS; Hughes LE; Whitehead RH; Newcombe RG
    Cancer Immunol Immunother; 1986; 21(1):1-5. PubMed ID: 3632914
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic relevance of immunologic variables in breast carcinoma.
    Baral E; Blomgren H; Petrini B; Wasserman J; Ogenstad S; Silfverswärd C
    Acta Radiol Ther Phys Biol; 1977 Oct; 16(5):417-26. PubMed ID: 602812
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of operation on peripheral lymphocyte counts and production of adenosine triphosphate (ATP) in cancer patients.
    Mukherjee M; Sahasrabuddhe MB
    J Surg Oncol; 1982 May; 20(1):1-8. PubMed ID: 7078179
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The accuracy of eosinophil counts.
    HUDSON B; BINET FE
    Aust J Exp Biol Med Sci; 1956 Dec; 34(6):479-83. PubMed ID: 13425983
    [No Abstract]   [Full Text] [Related]  

  • 75. Pre-treatment general immune competence and prognosis in breast cancer. A prospective 2-year follow-up.
    Teasdale C; Hillyard JW; Webster DJ; Bolton PM; Hughes LE
    Eur J Cancer (1965); 1979 Jul; 15(7):975-82. PubMed ID: 488155
    [No Abstract]   [Full Text] [Related]  

  • 76. [Protozoal and metazoal infectious diseases with special reference to eosinophil counts and giardiasis (author's transl)].
    Satomi N; Nishiya H; Haranaka K; Kunii O; Miwa S; Ebisawa I; Shibuya T
    Kansenshogaku Zasshi; 1980 May; 54(5):250-5. PubMed ID: 6772715
    [No Abstract]   [Full Text] [Related]  

  • 77. Eosinophil density: what does it mean?
    Wardlaw A
    Clin Exp Allergy; 1995 Dec; 25(12):1145-9. PubMed ID: 8821292
    [No Abstract]   [Full Text] [Related]  

  • 78. [Immunologic efficiency in patients with breast neoplasms. II. General immunological response in a group of 40 persons treated surgically].
    Smolak K; Cadel Z
    Nowotwory; 1977; 27(4):275-84. PubMed ID: 604941
    [No Abstract]   [Full Text] [Related]  

  • 79. A flow system adaptation of the SCM test for detection of lymphocyte response in patients with recurrent breast cancer.
    Stewart S; Pritchard KI; Meakin JW; Price GB
    Clin Immunol Immunopathol; 1979 Jun; 13(2):171-81. PubMed ID: 156612
    [No Abstract]   [Full Text] [Related]  

  • 80. Baseline absolute lymphocyte count as a prognostic indicator in advanced or metastatic breast cancer: a systematic review and meta-analysis.
    Xia G; Zhang Z; Jing S; Liu W
    Am J Transl Res; 2024; 16(9):5049-5062. PubMed ID: 39398610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.